The largest database of trusted experimental protocols

Nsg mice

Manufactured by Shanghai Model Organisms
Sourced in China

NSG mice are a strain of immunodeficient mice developed for use in biomedical research. They are characterized by the lack of functional T cells, B cells, and natural killer cells, making them suitable for the engraftment of human cells and tissues. NSG mice provide a versatile platform for the study of human diseases and the evaluation of potential therapies.

Automatically generated - may contain errors

9 protocols using nsg mice

1

Xenograft Leukemia Mouse Model Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
NSG mice were purchased from Shanghai Model Organisms Center, Inc. Luc-Molm13 cells, at a quantity of 5 × 103, were intravenously injected into NSG mice via tail vein to establish a xenograft mouse model. 6 days after injection, 25 mice were randomly divided into five groups (n = 5). These groups received intravenous treatments of PBS, oridonin, orid-liposome, orid-liposome-MAL, TLR2 pep-orid-liposome at a dose of 5 mg/kg, or PBS as control every other day. Live imaging was conducted at intervals of 5 ~ 6 days to monitor the progression of the disease. Additionally, survival and body mass of these mice were closely monitored during the treatment.
+ Open protocol
+ Expand
2

Glioma Xenograft Mouse Models and Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four to five-week-old female nude BALB/c mice (Beijing HFK Bioscience Co., Ltd) and five to six-week-old female NSG mice (Shanghai Model Organisms) were used for subcutaneous xenograft models. All experiments were approved by the Ethics Committee of Harbin Medical University (HMU, Harbin, Heilongjiang, China) according to the Guidelines for the Care and Use of Laboratory Animals. Ln229 glioma cells were subcutaneously transplanted into back flanks of BALB/c nude mice. After transplanted for 2 weeks, human recombinant murine IL-33 (carrier-free, R&D Systems) or PBS was administered intraperitoneally (i.p.) into mice at 1 μg per injection for 10 days. All nude mice were killed in the fourth week. Ln229 glioma cells were subcutaneously transplanted into back flanks of NSG mice. After transplanted for 3 weeks, PBS, Anti-ST2, TMZ and Anti-ST2+TMZ were administered intraperitoneally (i.p.) into mice for consecutive 7 days. All NSG mice were killed in the sixth week.
+ Open protocol
+ Expand
3

CAR-T Therapy for Subcutaneous Tumor Xenograft

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NSG mice (3–4 weeks old, female, 15–20 g) used in this study were obtained from the Shanghai Model Organisms Center (Shanghai, China). A total of 5 × 106 NKYS-Luciferase cells were mixed with isopycnic Matrigel (Corning Incorporated, USA) and implanted subcutaneously in mice. The mice in treatment groups (n = 6 per group) received an intravenous tail vein injection of 4 CAR-T cells or control T cells on days 15 and 18 after tumour implantation, with a total of 1 × 107 T cells infused per mouse (approximately 4 × 106 transduced cells). Mice in the blank group were not treated. The tumour size was measured with a vernier calliper every 3 days for the first 50 days after implantation and daily after 50 days. The mice were given D-luciferin (150 mg/kg, i.p.) and anaesthetized with isoflurane. After 5 min, luminescence was detected using an in vivo imaging system (IVIS), and the intensity was quantitated and normalized with the Living Image software (PerkinElmer, MA, USA). A tumour size of 1000 mm3 or death of a mouse was considered an end event. After 75 days, the mice were euthanized by cervical dislocation.
+ Open protocol
+ Expand
4

CAR-T Cell Therapy in NSG Mouse Xenograft

Check if the same lab product or an alternative is used in the 5 most similar protocols
NSG mice (3–4 weeks old, female, 15–20 g) used in this study were obtained from Shanghai Model Organisms Center. A total of 5 × 106 RPMI8226‐Luciferase cells in 200 μL medium were mixed with isopycnic matrigel (Corning Incorporated) and implanted subcutaneously into the abdominal wall of mice. Ten days after tumor implantation, treatment groups of mice (n = 6 per group) received tail intravenous injection of CAR‐T or control T cells at Days 12 and 17 with a total of 5 × 106 T cells per mice (about 2 × 106 transduced cells). Mice in blank group were untreated. Animal experiments were conducted in accordance with the Declaration of Helsinki and approved by the Institutional Research Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Lot No. 2022‐KY‐1062). Mice were given D‐Luciferin (150 mg/kg, i.p.) and anesthetized with isoflurane. After 5 min, luminescence was detected using the in vivo imaging system (IVIS) and the intensity was quantitated and normalized by the Living Image software (PerkinElmer).
+ Open protocol
+ Expand
5

Circulating PDHK1 siRNA Inhibits Tumor Growth

Check if the same lab product or an alternative is used in the 5 most similar protocols
786-O and Caki-1 subcutaneous tumor-bearing male NSG mice were purchased from the Shanghai Model Organisms Center and randomly assigned to groups based on tumor size. In the siRNA xenograft tumor model group (n = 6, each group), cholesterol-modified circPDHK1-siRNA (10 nmol, GenePharma) was intratumorally injected once every two days for five consecutive weeks. Tumor volumes were measured every 2 d. Tumor tissues were excised and weighed after mice were euthanized, fixed, and stained for immunohistochemistry. In the xenograft tumor model overexpression group (n = 5, each group), a lentiviral vector containing cloned inserts (Oligobio, Beijing) was injected intratumorally for 18 days. Tumor volume measurements and processing were carried out as described above. For the lung metastasis model, stably transfected Caki-1 cells (6 × 106 cells/0.2 mL PBS) were injected into the tail vein of 4-week-old male mice. After 48 days, the mice were assessed using the Aura Spectral Instruments in vivo Imaging System and sacrificed. Lung tissues were excised, photographed, and stained with hematoxylin and eosin (H&E), and the lung metastatic nodes were observed. All the animal experiments were conducted according to the protocol approved by the Ethics Committee of Chongqing Medical University (approval number: 2022013).
+ Open protocol
+ Expand
6

Lipid Metabolism in NSG Mice Xenograft

Check if the same lab product or an alternative is used in the 5 most similar protocols
NSG mice (6–8 weeks old) were purchased from SHANGHAI MODEL ORGANISMS (Shanghai, China). All animal experiments were approved by the Animal Care and Use Committee at Xuzhou Medical University. The stable cells were resuspended in a serum-free medium (5 × 107 cells /mL). NSG mice were randomly divided into the control group (Vector), TRIM21 overexpression group (OE-TRIM21), SREBF1 overexpression group (OE-SREBF1), and TRIM21 + SREBF1 double overexpression group (OE-TRIM21 + OE-SREBF1). Mice were anesthetized with isoflurane, after the kidney was exposed from the posterior side, the cell suspension (5 × 105 cells /10μL) was injected under the renal capsule, and the wound was sutured and sterilized. Every 7 days in vivo imaging of small animals was used to monitor tumor size and metastasis. The experiment was terminated when the difference in tumor growth between groups was fully developed. The orthotopic tumors were collected for frozen sections to detect the formation of lipid droplets. Paraffin embedding and histochemical staining were performed to detect the expression of lipid metabolism-related indicators.
+ Open protocol
+ Expand
7

Xenograft Tumor Model in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All procedures performed on animals were in accordance with regulations and established guidelines and were reviewed and approved by the Institutional Animal Care and Use Committee at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (IACUC Issue NO. 2022-01-JHL-27 for NSG mice; IACUC Issue NO. 2021-03-JHL-22 for BALB/c mice). NSG mice were obtained from Shanghai Model Organisms Center, Inc; BALB/c mice were obtained from Beijing Huafukang Biotechnology Co. Ltd (Beijing, China). Six- to eight-week-old mice were used for the studies and were maintained with free access to pellet food and water in plastic cages at 21 ± 2 °C and humidity (50 ± 10%) conditions and kept on a 12 h light/dark cycle. The tumor size tolerated by the xenograft tumor model mice did not exceed 2000 mm3, the maximal tumor burden permitted by the Institutional Animal Care and Use Committee at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences.
+ Open protocol
+ Expand
8

Xenograft Tumor Growth and Gene Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiments were performed according to the protocols approved by the Institutional Animal Care and Use Committee (IACUC) of Southern Medical University. For xenograft tumor growth, 5 × 106 cells were injected subcutaneously into the left (control group) and the right (SLC35B4 knockdown group) flanks of the immunodeficient NSG mice (purchased from Shanghai Model Organisms, Shanghai, China. n = 6), respectively. For inducible gene knockdown, the drinking water containing 2 mg/L of doxycycline was supplied with doxycycline (20 mg/kg body weight) injected intraperitoneally every day.
After obtaining adequate informed consent, HCC tissue and adjacent normal tissue (ANT, exceeding the edge of the tumor by at least 2 cm) were obtained from HCC patients who underwent curative resection for HCCs in Nanfang Hospital of Southern Medical University, Guangzhou, China, between November 2010 and May 2015. This study was approved by IRB of Nanfang Hospital at Southern Medical University and was performed according to the Declaration of Helsinki (6th revision, 2008).
+ Open protocol
+ Expand
9

Preclinical Tumor Immunotherapy Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were housed in a specific pathogen-free barrier facility. All the in vivo experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Second Military Medical University. For mouse models with human T cells, tumour-reactive T cells were expanded in culture with mitomycin C-treated cancer cells for 10 days in RPMI 1640 supplemented with 10% FBS and IL2. Tumour-reactive T cells or subsets were mixed with A375 cells at a 1:5 ratio, and the cell mixtures were implanted by subcutaneous injection of 5 ×10 6 cells into the flank of NSG mice (Shanghai Model Organisms Center, Inc.). Different drugs were administered i.p. 1 hr immediately after implantation. For syngeneic tumour models, MC38 or CT26 cells were inoculated into C57BL/6 mice or BALB/c mice. For tumour xenograft models, CT26, A431, SK-BR-3 or SK-OV-3 cells were inoculated into BALB/c nude mice (Shanghai Experimental Animal Center of Chinese Academy of Sciences) or NSG mice. When tumour volumes reached an average of approximately 50 mm 3 , the mice were randomly divided into groups of 8 mice each. Multiple dose studies consisted of 3 weeks of treatment, with a 2× loading dose on the first dose (day of randomization). Tumour volumes were calculated by the following formula: volume = length × (width) 2 /2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!